Anti-GSTM3 / Glutathione S-Transferase mu 3

0.5mg/ml if reconstituted with 0.2ml sterile DI water. GSTM3 antibody targets Glutathione S-Transferase mu 3, encoded by the GSTM3 gene. Glutathione S-Transferase mu 3 is a member of the mu class of glutathione S-transferases, a family of phase II detoxification enzymes that catalyze the conjugation of reduced glutathione to a wide range of electrophilic compounds. This enzymatic activity supports cellular defense against oxidative stress, xenobiotics, and endogenous toxic metabolites. GSTM3 is primarily localized in the cytoplasm, where it participates directly in cellular detoxification processes.Functionally, Glutathione S-Transferase mu 3 contributes to the neutralization and elimination of reactive oxygen species-derived products and environmental toxins. By conjugating glutathione to reactive substrates, GSTM3 increases their solubility and facilitates subsequent excretion. In addition to its catalytic role, GSTM3 has been implicated in modulating intracellular signaling pathways related to stress responses and apoptosis, linking detoxification capacity to broader cellular survival mechanisms. A GSTM3 antibody supports studies focused on oxidative stress biology and cellular detoxification pathways.GSTM3 expression is observed in multiple tissues, with notable expression in liver, lung, kidney, and gastrointestinal tract, organs that are frequently exposed to metabolic byproducts and environmental chemicals. Expression can vary between individuals due to genetic polymorphisms within the GSTM locus, which influence enzyme activity and detoxification efficiency. These variations have been studied extensively in the context of susceptibility to oxidative stress and chemical exposure. The tissue distribution of GSTM3 highlights its importance in maintaining redox balance and cellular protection across organ systems.From a disease-relevance perspective, Glutathione S-Transferase mu 3 has been investigated in cancer biology, toxicology, and pharmacogenomics. Altered GSTM3 expression or activity has been associated with cancer risk, tumor progression, and response to chemotherapy, reflecting its role in metabolizing carcinogens and therapeutic agents. GSTM3 has also been studied in respiratory and liver diseases, where impaired detoxification and oxidative damage contribute to disease pathogenesis. These associations have made GSTM3 a molecule of interest in studies examining environmental exposure, drug metabolism, and disease susceptibility.At the molecular level, GSTM3 encodes a protein with an apparent molecular weight of approximately 26 to 28 kDa. The protein contains conserved domains characteristic of the mu class GSTs, including a glutathione-binding site and a substrate-binding region. Enzymatic activity and stability of GSTM3 can be influenced by cellular redox state and post-translational modifications. A GSTM3 antibody supports research applications focused on detoxification enzyme expression, oxidative stress responses, and disease-associated changes in cellular defense mechanisms, with NSJ Bioreagents providing reagents intended for research use.